It’s been a year of putting patient centricity theory into practice, as companies and industry organisations alike have shared their advice and embraced emerging technologies.
While immunotherapy has transformed the treatment of many cancers, it has failed to make much of an impact in advanced ovarian cancer, and AstraZeneca is hoping to change
